BDBM199527 (1r,5s,7s)-3-oxa-9-azabicyclo[3.3.1]nonan- 7-yl 1-(1-methyl-1h-pyrazol-5-yl)-1h- indole-3-carboxylate, 2,2,2-trifluoroacetic acid salt::US10125145, Cpd. No. 25::US9670229, 25

SMILES CN1C2COCC1CC(C2)NC(=O)c1cn(-c2cnn(c2)C(F)F)c2ccccc12

InChI Key InChIKey=KKCAKHUUDWQJGI-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 199527   

Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM199527((1r,5s,7s)-3-oxa-9-azabicyclo[3.3.1]nonan- 7-yl 1-...)
Affinity DataIC50:  1.39nMAssay Description:The 5-HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM199527((1r,5s,7s)-3-oxa-9-azabicyclo[3.3.1]nonan- 7-yl 1-...)
Affinity DataIC50:  1.39nMT: 2°CAssay Description:The 5-HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent